Background & Aims: Hepatocellular carcinoma (HCC) has become a major cause of liver-related death and indication to liver transplantation (LT) in patients with chronic hepatitis B virus (HBV) infection following the widespread adoption of antiviral therapy with nucleos(t)ide analogs (NUCs). Yet, the long-term outcome of patients undergoing liver transplantation for an HCC developed during effective NUC treatment is unknown. Methods: We evaluated 101 patients with persistently compensated cirrhosis who were consecutively transplanted for HCC in two centers in Milan. At LT, 91 (90%) patients had undetectable serum HBV DNA (<12 IU/ml) and 90 (89%) were within Milan criteria (MC). All patients received post-transplant HBV prophylaxis with specific immunoglobulins (HBIgs) and NUCs. End-points were long-term patient survival and recurrence of HCC and HBV. Results: During 106 (range 3-165) months following LT, HCC recurred in 11 (11%) patients (nine beyond MC at explant, two with HBV recurrence). Age (HR 1.1, 95%CI 1.0-1.2, P = 0.04) and exceeding MC (HR 9.6, 95%CI 2.9-32, P < 0.0001) were the only independent pretransplant predictors of tumour recurrence. The 10-year cumulative rate of HCC recurrence was 7% among patients transplanted within MC compared with 45% among those beyond MC at LT (P = 0.004). Overall, 18 patients (18%, nine HCC, nine non liver-related events) died with a 10-year cumulative probability of overall and liver-related survival of 79% and 89% respectively. Conclusions: Extended survival of HBV cirrhotics transplanted for HCC can be achieved by coupling MC at listing with persistent pharmacological suppression of HBV.
Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma / M. Viganò, S. Bhoori, P. Lampertico, M.F. Donato, M. Iavarone, G. Grossi, A. Facciorusso, L. Caccamo, G. Rossi, M. Colombo, V. Mazzaferro. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - 35:9(2015), pp. 2187-2193.
|Titolo:||Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma|
COLOMBO, MASSIMO GIUSEPPE (Penultimo)
|Parole Chiave:||HBV; HCC; hepatitis B immunoglobulin; liver transplantation; nucleos(t)ide analogs; hepatology|
|Settore Scientifico Disciplinare:||Settore MED/18 - Chirurgia Generale|
|Data di pubblicazione:||2015|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1111/liv.12835|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.pdf||Publisher's version/PDF||Administrator Richiedi una copia|